Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-25T04:55:18.979Z Has data issue: false hasContentIssue false
  • English
  • Français

Oestrogens and other biochemical and cytological components in nipple aspirates of breast fluid: relationship to risk factors for breast disease

Published online by Cambridge University Press:  05 December 2011

Nicholas L. Petrakis
Nicholas L. Petrakis
Affiliation:
Department of Epidemiology and International Health, School of Medicine, University of California, San Francisco, CA 94143-0560, U.S.A.
Get access

Synopsis

The breast of the nonpregnant woman secretes, retains or reabsorbs a variety of endogenous and exogenous biochemical substances of potential physiological and clinical significance. Among these substances are steroid hormones, prolactin, growth hormones, and peptide growth factors. Because the concentrations of these hormones secreted into the breast ducts are often significantly higher than the concentrations in serum, the breast epithelium is commonly exposed to very high concentrations of steroid and other hormones which may play a role in the aetiology and pathogenesis of breast disease.

This paper presents a brief review of published data on the cytological and biochemical constituents of breast fluid obtained by nipple aspiration and data on factors affecting oestradiol and oestrone concentrations in breast fluid. Concentrations of oestradiol and oestrone in nipple aspirate fluid are much higher than in serum, not correlated with serum levels, much lower in women who recently have given birth or breast-fed their infants, not related to day in menstrual cycle, and higher in women with biopsied benign breast disease compared with nulliparous women without breast disease.

Further studies of the interrelationships of hormones, other biochemical constituents and the cytopathology of breast fluid may provide new insights into the pathophysiology and aetiology of breast diseases.

Type
Research Article
Information
Proceedings of the Royal Society of Edinburgh, Section B: Biological Sciences , Volume 95: Oestrogen and the Human Breast , 1989 , pp. 169 - 181
Copyright
Copyright © Royal Society of Edinburgh 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abul-Hajj, Y. J., Iverson, R. & Kiang, D. T. 1979. Aromatization of androgens by human breast cancer. Steroids 33, 205–222.Google Scholar
Adair, F. E. & Bagg, H. J. 1925. Breast stasis as the cause of mammary cancer. International Clinics 4, 19–26.Google Scholar
Adams, J. B. & Li, K. 1975. Biosynthesis of 17-β-oestradiol in human breast carcinoma tissue and a novel method for its characterization. British Journal of Cancer 31, 429–433.Google Scholar
American Academy of Pediatrics, Committee on Drugs 1983. The transfer of drugs and other chemicals into human breast milk. Pediatrics 72, 375–383.CrossRefGoogle Scholar
Bischoff, F. 1969. Carcinogenic effects of steroids. Advances in Lipid Research 7, 165–244.Google Scholar
Black, M. M. & Chabon, A. B. 1969. In situ carcinoma of the breast. Pathology Annual 4, 185–210.Google Scholar
Boccozzi, G., Briganardello, E., Massobrio, M. & Bonino, L. 1987. Breast duct dehydroepiandrosterone sulfate in fibrocystic disease. European Journal of Cancer and Clinical Oncology 23, 1099–1102.CrossRefGoogle Scholar
Bonser, G. M., Dossett, S. A. & Jull, S. W. 1961. Human and Experimental Breast Cancer. Springfield, IL: CC Thomas.Google Scholar
Bradlow, H. L., Skidmore, F. D., Schwartz, M. K. & Fleischer, M. 1981. Cation levels in human breast cyst fluid. Clinical Oncology 7, 388–390.Google Scholar
Bradlow, H. L., Schwartz, M. K., Fleisher, M., Rosenfeld, R. S., Kream, J., Schwartz, D., Breed, C. N. & Fracchia, A. A. 1983. Hormone levels in human breast cyst fluid. In Angeli, A., Bradlow, H. L. & Dogliotti, L. (eds) Endocrinology of Cystic Breast Disease, pp. 59–75. New York: Raven Press.Google Scholar
Buehring, G. C. 1979. Screening for breast atypias using exfoliative cytology. Cancer 43, 1788–1799.Google Scholar
Carter, C. L., Carle, D. K., Micozzi, M. S., Schatzkin, A. & Taylor, P. R. 1988. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. American Journal of Epidemiology 128, 467–477.CrossRefGoogle Scholar
Cheattle, G. L. 1923. Desquamative and dysgenetic epithelial hyperplasia in the breast: their actuation and characteristics; their likeness to lesions induced by tar. British Journal of Surgery 11, 89–121.Google Scholar
Cole, P., Cramer, D. & Yen, S. 1978. Estrogen profile of premenopausal women with breast cancer. Cancer Research 38, 745–748.Google ScholarPubMed
Connolly, J. M. & Rose, D. P. 1988. Epidermal growth factor-like proteins in breast fluid and human milk. Life Sciences 42, 1751–1756.CrossRefGoogle ScholarPubMed
Dupont, W. D. & Page, D. L. 1985. Risk factors for breast cancer in women with proliferative breast disease. New England Journal of Medicine 312, 146–151.Google Scholar
Ernster, V. L., Wrensch, M. R., Petrakis, N. L., King, E. B., Miike, R., Murai, J., Goodson, W. H. III & Siiteri, P. K. 1987. Benign and malignant breast disease: Initial study results of serum and breast fluid analyses of endogenous estrogens. Journal of the National Cancer Institute 79, 949–960.Google Scholar
Gatzy, J. T., Zayloun, M. P., Gaskins, K. & Pearlman, W. H. 1979. Electrolytes of breast cyst fluid. Clinical Chemistry 25, 745–748.Google Scholar
Gruenke, L. D., Craig, J. C., Petrakis, N. L. & Lyon, M. B. 1987a. Analysis of cholesterol, cholesterol 5,6-epoxides and cholestane 3β,5α,6β-triol in nipple aspirates of human breast fluid by gas chromatography/mass spectrometry. Biomedical and Environmental Mass Spectrometry 14, 335–338.Google Scholar
Gruenke, L. D., Wrensch, M. R., Petrakis, N. L., Miike, R., Ernster, V. L. & Craig, J. C. 1987b. Breast fluid cholesterol and cholesterol epoxides: Relationship to breast cancer risk factors and other characteristics. Cancer Research 47, 5483–5487.Google Scholar
Hagler, L., Coppes, R. I., Block, M. B., Hofeldt, F. D. & Herman, R. H. 1975. Clinical implications of lactose-positive breast secretions in nonpuerperal females. Obstetrics and Gynecology 46, 302–307.Google ScholarPubMed
Hill, P., Garbaczewski, L. & Wynder, E. L. 1983. Testosterone in breast fluid. Lancet 1, 761.Google Scholar
Hutchinson, W. B., Thomas, D. B., Hamlin, W. B., Roth, G. J., Peterson, A. V. & Williams, B. 1980. Risk of breast cancer in women with benign breast disease. Journal of the National Cancer Institute 65, 13–20.Google Scholar
Kelsey, M. I. & Pienta, R. J. 1981. Transformation of hamster embryo cells by cholesterol α-epoxide and lithocholic acid. Toxicology Letters 9, 177–182.Google Scholar
Keynes, G. 1923. Chronic mastitis. British Journal of Surgery 11, 89–121.Google Scholar
King, E. B., Barrett, D., King, M.-C. & Petrakis, N. L. 1975a. Cellular composition of the nipple aspirate specimen of breast fluid. I. The benign cells. American Journal of Clinical Pathology 64, 728–738.CrossRefGoogle ScholarPubMed
King, E. B., Barrett, D. & Petrakis, N. L. 1975b. Cellular composition of the nipple aspirate specimen of breast fluid. II. Abnormal findings. American Journal of Clinical Pathology 64, 739–748.Google Scholar
King, E. B., Chew, K. L., Petrakis, N. L. & Ernster, V. L. 1983. Nipple aspirate cytology for the study of breast cancer precursors. Journal of the National Cancer Institute 71, 1115–1121.Google Scholar
Kodlin, D., Winger, E. E., Morgenstern, N. L. & Chen, U. 1977. Chronic mastopathy and breast cancer. A follow-up study. Cancer 39, 2603–2607.Google Scholar
Li, K., Chandra, T., Foo, T., Adams, J. B. & McDonald, D. 1976. Steroid metabolism by human mammary carcinoma. Steroids 28, 561–574.Google Scholar
Lowry, et al. 1951. Journal of Biological Chemistry 193, 665–675.Google Scholar
MacMahon, B., Cole, P. & Brown, J. 1973. Etiology of human breast cancer: A review. Journal of the National Cancer Institute 50, 21–42.Google Scholar
Matsunaga, E. 1962. The dimorphism in human normal cerumen. Annals of Human Genetics 25, 273–286.Google Scholar
Miller, W. R., Hawkins, R. A., Creel, R. J. & Forrest, A. P. M. 1977. Oestrogens in breast fluid. Lancet 2, 1179.Google Scholar
Miller, W. R., Humeniuk, V. & Kelly, R. W. 1980. Dehydroepiandrosterone sulfate in breast secretions. Journal of Steroid Biochemistry 13, 145–151.Google Scholar
Miller, W. R., Humeniuk, V. & Forrest, A. P. M. 1981. Factors affecting dehydroepiandrosterone sulfate levels in human breast secretions. Breast Cancer Research and Treatment 1, 267–272.Google Scholar
Miller, W. R., Dixon, J. M., Scott, W. N. & Forrest, A. P. M. 1983. Classification of human breast cysts according to electrolyte and androgen conjugate composition. Clinical Oncology 9, 227–232.Google ScholarPubMed
Miller, W. R., Dixon, J. M. & Forrest, A. P. M. 1986. Hormonal correlates of apocrine secretion in the breast. Annals of the New York Academy of Science 464, 275–287.Google Scholar
Miller, W. R. & Forrest, A. P. M. 1976. Oestradiol synthesis from C19 steroids by human breast cancers. British Journal of Cancer 33, 116–118.Google Scholar
Papanicolaou, G. N., Holmquist, D. G., Bader, G. M. & Falk, E. A. 1958. Exfoliative cytology of the human mammary gland and its value in the diagnosis of cancer and other diseases of the breast. Cancer 11, 377–409.Google Scholar
Perel, E., Wilkins, D. & Killinger, D. W. 1980. The conversion of androsterone to estrone, estradiol, and testosterone in breast tissue. Journal of Steroid Biochemistry 13, 89–94.Google Scholar
Perel, E., Stolee, K. J., Kharlip, M. E., Blackstein, M. E. & Killinger, D. W. 1984. Androstenedione metabolism in epithelial cells derived from early-lactation human milk. Steroids 42, 389–399.Google Scholar
Petrakis, N. L. 1971. Cerumen genetics and human breast cancer. Science 173, 347–349.Google Scholar
Petrakis, N. L. 1983. Cerumen phenotype and epithelial dysplasia in nipple aspirates of breast fluid. American Journal of Physical Anthropology 62, 115–118.Google Scholar
Petrakis, N. L. 1986. Physiologic, biochemical, and cytologic aspects of nipple aspirate fluid. Breast Cancer Research and Treatment 8, 7–19.Google Scholar
Petrakis, N. L., Doherty, M., Lee, R., Mason, L., Pawson, S., Hunt, T. K. & Schweitzer, R. 1977. Immunoglobulin levels in breast fluids of women with breast cancer. Clinical Immunology and Immunopathology 7, 386–393.Google Scholar
Petrakis, N. L., Gruenke, L. D., Beelen, T. C., Craig, J. C. & Castagnoli, N. Jr., 1978. Nicotine in breast fluid of nonlactating women. Science 199, 303–305.Google Scholar
Petrakis, N. L., Maack, C. A., Lee, R. E. & Lyon, M. 1980. Mutagenic activity of nipple aspirates of breast fluid. Cancer Research 40, 188–189.Google Scholar
Petrakis, N. L., Ernster, V. L., Sacks, S. T., King, E. B., Schweitzer, R. J., Hunt, T. K. & King, M.-C. 1981a. Epidemiology of breast fluid secretion: Association with breast cancer risk factors and cerumen type. Journal of the National Cancer Institute 67, 277–284.Google Scholar
Petrakis, N. L., Gruenke, L. D. & Craig, J. C. 1981b. Cholesterol and cholesterol epoxides in nipple aspirates of human breast fluid. Cancer Research 41, 2563–2565.Google Scholar
Petrakis, N. L., Dupuy, M. E., Lee, R. E., Lyon, M., Maack, C. A., Gruenke, L. D. & Craig, J. C. 1982. Mutagens in nipple aspirates of breast fluid. Banbury Report 13, 67–82.Google Scholar
Petrakis, N. L., Ernster, V. L., Wrensch, M. R. & Miike, R. 1987a. Serum estrogen levels in breast fluid secretors and nonsecretors. Medical Science Research 15, 1273–1274.Google Scholar
Petrakis, N. L., Wrensch, M. R., Ernster, V. L., Miike, R., King, E. B. & Goodson, W. H. III 1987b. Prognostic significance of atypical epithelial hyperplasia in nipple aspirates of breast fluid. Lancet 2, 505.CrossRefGoogle ScholarPubMed
Petrakis, N. L., Wrensch, M. R., Ernster, V. L., Miike, R., Murai, J., Simberg, N. & Siiteri, P. K. 1987c. Influence of pregnancy and lactation on serum and breast fluid estrogen levels: Implications for breast cancer risk. International Journal of Cancer 40, 587–591.Google Scholar
Petrakis, N. L., Lee, R. E., Miike, R., Dupuy, M. E. & Morris, M. 1988a. Coloration of breast fluid related to concentration of cholesterol, cholesterol epoxides, estrogen and lipid peroxides. American Journal of Clinical Pathology 89, 117–120.Google Scholar
Petrakis, N. L., Miike, R., King, E. B., Lee, L., Mason, L. & Lee, B. C. 1988b. Association of breast fluid coloration with age, ethnicity, and cigarette smoking. Breast Cancer Research and Treatment 11, 255–262.Google Scholar
Petrakis, N. L., Lim, M. L., Miike, R., Lee, R. E., Morris, M., Lee, L. & Mason, L. 1989. Nipple aspirate fluids in adult nonlactating women—lactose content, cationic Na +, K +, Na + /K + ratio, and coloration. Breast Cancer Research and Treatment 13, 71–78.Google Scholar
Rose, D. P. 1986. Hormones in breast fluid. Breast Cancer Research and Treatment 8, 25–28.Google Scholar
Rose, D. P., Lahti, H., Laakso, K., Kettunen, K. & Wynder, E. L. 1986a. Serum and breast duct prolactin and estrogen levels in healthy Finnish and American women and patients with fibrocystic disease. Cancer 57, 1550–1554.Google Scholar
Rose, D. P., Tilton, K., Lahti, H. & Wynder, E. L. 1986b. Progesterone levels in breast duct fluid. European Journal of Cancer and Clinical Oncology 22, 111–113.Google Scholar
Rose, D. P., Boyar, A. P. & Kettunen, K. 1988. Diet, serum, breast fluid growth hormone, and prolactin levels in normal premenopausal Finnish and American women. Nutrition and Cancer 11, 179–187.Google Scholar
Sartorius, O. 1973. Breast fluid cells help in early cancer detection. Journal of the American Medical Association 224, 823–827.Google Scholar
Sartorius, O. W., Smith, H. S., Morris, P., Benedict, D. & Friesen, L. 1977. Cytologic evaluation of breast fluid in the detection of breast disease. Journal of the National Cancer Institute 59, 1073–1080.Google Scholar
Sevanian, A. & Peterson, A. R. 1984. Cholesterol epoxide is a direct acting mutagen. Proceedings of the National Academy of Science of the U.S.A. 81, 4198–4202.Google Scholar
Siiteri, P. K. 1982. Review of studies on estrogen biosynthesis in the human. Cancer Research [Supplement] 42, 3269s–3273s.Google ScholarPubMed
Tappel, A. L. 1980. Measurement of and protection from in vivo lipid peroxidation. In Prior, W. A. (ed.) Free Radicals in Biology. New York: Academic Press.Google Scholar
Tilson-Mallett, N., Santner, S. J., Feil, P. D. & Santner, R. S. 1983. Biological significance of aromatase activity in human breast tumours. Journal of Clinical Endocrinology and Metabolism 57, 1125–1128.Google Scholar
Wellings, S. R., Jensen, H. M. & Marcum, R. G. 1975. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. Journal of the National Cancer Institute 55, 231–273.Google ScholarPubMed
Wrensch, M. R., Petrakis, N. L., Gruenke, L. D., Miike, R., Ernster, V. L., King, E. B., Hauck, W. W., Craig, J. C. & Goodson, W. H. III 1989. Breast fluid cholesterol and cholesterol β-epoxide concentrations in women with benign breast disease. Cancer Research 49, 2168–2174.Google Scholar
Wynder, E. L., Hill, P., Laakso, K., Lettner, R. & Kettrinen, K. 1981. Breast secretion in Finnish women. Cancer 47, 1444–1450.Google Scholar
Wynder, E. L. & Hill, P. 1977. Prolactin, oestrogens, and lipids in breast fluid. Lancet 2, 840–842.Google Scholar
Yap, P. L., Miller, W. R., Humeniuk, V., Pryde, E. A. D., Mirtle, C. L. & McClelland, D. B. L. 1981. Milk protein concentrations in the mammary secretions of nonlactating women. Journal of Reproductive Immunolgy 3, 49–58.Google Scholar
Zumoff, B. 1982. Relationship of obesity to blood estrogens. Cancer Research [Supplement] 42, 3289s–3294s.Google Scholar